Product Information
XIIDRA 5% EYE DROPS is a brand product labeled by Bausch & Lomb Incorporated, priced at $11.8311 per EA under NDC 24208091112. Its NADAC has been published 86 times since Jan 1, 2025.
FDA first approved this application on Jul 11, 2016.
Strength
50 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208091112
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
LIFITEGRASTApproval Type
New Drug (NDA)
FDA Application
NDA208073FDA Approved
7/11/2016
On Market Since
1/2/2024
Pharmacological Classes
Price Statistics
The NADAC for XIIDRA 5% EYE DROPS has been published 86 times since Jan 1, 2025, and over the history we have for it it has risen 5.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.8311 per EA |
|---|---|
| All-time high | $11.8386 (May 13, 2026) |
| All-time low | $11.2331 (Jan 1, 2025) |
| 52-week high | $11.8386 |
| 52-week low | $11.4891 |
| Median price | $11.5139 |
| Average price | $11.6210 |
| Largest weekly change | +3.0% (Jan 14, 2026) |
| Weeks tracked | 86 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XIIDRA 5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for XIIDRA 5% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $11.8311 per EA (NDC 24208091112), effective Aug 19, 2026.
How has the price of XIIDRA 5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for XIIDRA 5% EYE DROPS has risen 5.3%. It has been tracked across 86 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for XIIDRA 5% EYE DROPS?
Since Jan 1, 2025, the NADAC for XIIDRA 5% EYE DROPS has ranged from a low of $11.2331 (Jan 1, 2025) to a high of $11.8386 (May 13, 2026), with a median of $11.5139 per EA.
Are there cheaper alternatives to XIIDRA 5% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as XIIDRA 5% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures XIIDRA 5% EYE DROPS?
XIIDRA 5% EYE DROPS (NDC 24208091112) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.